Cascade Financial Partners’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$25.2K	Buy	+17,000	New	+$25.2K	﹤0.01%	259
2024 Q3	–	Sell	-11,100	Closed	-$13K	–	242
2024 Q2	$13K	Buy	+11,100	New	+$13K	﹤0.01%	233